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Background: Lyme disease is a tick-borne illness caused by the spirochete Borrelia burgdorferi.
Although antibiotic therapy is usually effective early in the disease, relapse may occur when
administration of antibiotics is discontinued. Studies have suggested that resistance and
recurrence of Lyme disease might be due to formation of different morphological forms of
B. burgdorferi, namely round bodies (cysts) and biofilm-like colonies. Better understanding
of the effect of antibiotics on all morphological forms of B. burgdorferi is therefore crucial to
provide effective therapy for Lyme disease.
Methods: Three morphological forms of B. burgdorferi (spirochetes, round bodies, and biofilmlike colonies) were generated using novel culture methods. Minimum inhibitory concentration
and minimum bactericidal concentration of five antimicrobial agents (doxycycline, amoxicillin,
tigecycline, metronidazole, and tinidazole) against spirochetal forms of B. burgdorferi were
evaluated using the standard published microdilution technique. The susceptibility of spirochetal and round body forms to the antibiotics was then tested using fluorescent microscopy
(BacLight™ viability staining) and dark field microscopy (direct cell counting), and these
results were compared with the microdilution technique. Qualitative and quantitative effects
of the antibiotics against biofilm-like colonies were assessed using fluorescent microscopy and
dark field microscopy, respectively.
Results: Doxycycline reduced spirochetal structures ∼90% but increased the number of round
body forms about twofold. Amoxicillin reduced spirochetal forms by ∼85%–90% and round
body forms by ∼68%, while treatment with metronidazole led to reduction of spirochetal structures by ∼90% and round body forms by ∼80%. Tigecycline and tinidazole treatment reduced
both spirochetal and round body forms by ∼80%–90%. When quantitative effects on biofilmlike colonies were evaluated, the five antibiotics reduced formation of these colonies by only
30%–55%. In terms of qualitative effects, only tinidazole reduced viable organisms by ∼90%.
Following treatment with the other antibiotics, viable organisms were detected in 70%–85%
of the biofilm-like colonies.
Conclusion: Antibiotics have varying effects on the different morphological forms of
B. burgdorferi. Persistence of viable organisms in round body forms and biofilm-like colonies
may explain treatment failure and persistent symptoms following antibiotic therapy of Lyme
disease.
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Lyme disease is a tickborne illness that was originally described in Old Lyme, Connecticut,
in 1975 and subsequently shown to be caused by the spirochete Borrelia burgdorferi.1–4 The
disease is transmitted by tick vectors of the genus Ixodes.2–4 The life cycle and distribution
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of these tick vectors involves rodents, reptiles, birds, and deer.2–4
Lyme disease sometimes begins with a skin rash called erythema
migrans following a tick bite. The rash may be followed a few
weeks or months later by fatigue, musculoskeletal symptoms,
neurologic problems, and/or cardiac abnormalities.1–4
Over the last 10 years, Lyme disease has grown into a major
public health problem in the USA and central Europe.5–7 The
disease occurs in all age groups with equal prevalence in men
and women.5–7 In the United States, the Centers for Disease
Control and Prevention (CDC) reported that the number of
Lyme disease cases has doubled during the last 15 years.5 In
2008, a total of 3896 cases of Lyme borreliosis were reported
in Connecticut.5 However, these figures do not reflect the
true incidence of Lyme disease because in 2003 Connecticut
stopped requiring mandatory laboratory reporting of the
disease.5 Therefore, the true number of Lyme disease cases
may be at least 10-fold higher than reported.5–7 The increasing
trend of the disease has been ascribed to ineffective preventive
measures, suboptimal treatment regimens, and incomplete
understanding of the nature of the causative spirochete.
The frontline treatment for Lyme disease is administration
of antibiotics such as doxycycline, minocycline, amoxicillin,
cefuroxime, and ceftriaxone.8–14 Although treatment of early
Lyme disease is generally successful, studies have shown
that in spite of short-course antibiotic therapy of 2–4 weeks,
some patients are not successfully treated and go on to develop
persistent Lyme disease symptoms.8–11 Also, in the absence of
sufficient antibiotic treatment in animals and humans, relapse of
the disease may occur, suggesting that even after antibiotic treatment, the host immune system fails to prevent recurrence.12–14
A possible explanation for this clinical observation is the presence of different morphological forms of B. burgdorferi with
differences in sensitivity to the antibiotic treatment.15–30
In this study, we developed novel evaluation methods
involving optimal culture conditions for three different forms
of B. burgdorferi (spirochetes, round bodies, and biofilm-like
colonies) and improved bacterial viability determination
techniques. These techniques were used to test the effectiveness of antibiotics commonly used for Lyme disease treatment against the different forms of B. burgdorferi. Our goal
was to establish a useful in-vitro system to mimic the in-vivo
effects of antibiotics on B. burgdorferi in order to develop
better therapeutic approaches for Lyme disease.

Materials and methods
Culturing B. burgdorferi
Low passage isolates of the B31 and S297 strains of
B. burgdorferi were obtained from the American Type
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 ulture Collection, Manassas, VA. B. burgdorferi was
C
cultured in Barbour-Stoner-Kelly H (BSK-H) complete
medium, with 6% rabbit serum (Sigma, St Louis, MO,
#B8291). The cultures were incubated at 33°C with 5%
CO2 and maintained in sterile 15 mL glass tubes without
antibiotics. Homogeneous cultures having only one form
(spirochete) of B. burgdorferi were obtained by maintaining the cultures in a shaking incubator at 33°C and 250 rpm.
At 250 rpm, there is no biofilm formation, and the culture
remains homogeneous (E Sapi, unpublished observation).
The methods for generation and detection of round body
forms of B. burgdorferi using culture tubes and dark field or
fluorescent microscopy are described below. For generation of
biofilm-like colonies of B. burgdorferi, spirochetes were inoculated in four-well chambers (BD BioCoat™ CultureSlides,
BD Biosciences, Sparks, MD, #354557) or 24-well plates (BD
BioCoat™ Multiwell Plates, BD Biosciences, Sparks, MD,
#354408) coated with rat-tail collagen type I and incubated
for 1 week without shaking. After the 1-week incubation,
biofilm-like colonies were visualized using the qualitative
and quantitative methods described below.

In-vitro testing of the antibacterial agents
Standard microdilution technique

To determine the minimum inhibitory concentration (MIC)
of the antibiotics tested (the lowest concentration that will
inhibit visible growth of B. burgdorferi spirochetes after
a 72-hour incubation period), a standard microdilution
method was used.31–33 For this procedure, 1 × 106 spirochetes
were inoculated into each well of a 48-well tissue culture
microplate containing 1 mL of BSK-H medium per well.
The cultures were then treated with 100 µL of each antibiotic
diluted in phosphate-buffered saline (PBS). Control cultures
were treated with PBS alone, and all experiments were run
in triplicate. The well plate was covered with parafilm and
placed in the incubator for 72 hours. Cell proliferation was
assessed using a bacterial counting chamber (Petroff-Hausser
Counter-3902) after the 72-hour incubation.
To determine the minimum bactericidal concentration
(MBC) of the antibiotics tested (the minimum concentration beyond which no spirochetes can be subcultured after a
3-week incubation period), wells of a 48-well plate were filled
with 1 mL of BSK-H medium, and 20 µL of antibiotic-treated
spirochetes were added into each of the wells, in triplicate.
The well plate was wrapped with parafilm and placed in the
incubator for 3 weeks (21 days). After the incubation period,
the plate was removed and observed for motile spirochetes
in the culture.

Infection and Drug Resistance 2011:4

Dovepress

Dark field microscopy and fluorescent microscopy
To further test the effect of antibiotics on spirochete and
round body forms of B. burgdorferi, the antibiotics were
added to a set of 2-mL polystyrene culture tubes containing
spirochetes at a concentration of 1 × 106 cells/mL and incubated at 33°C with 5% CO2. These cultures were incubated
for various time periods (24 hours, 48 hours, 72 hours,
and 3 weeks) and cellular growth was scored. For each of
these timepoints, cell proliferation assays were performed
by directly counting the different morphological forms
of B. burgdorferi using a bacterial counting chamber and
dark field microscopy. Also, by performing LIVE/DEAD®
BacLight™ Bacterial Viability Assay (Molecular Probes,
Inc, Eugene, OR), the ratio of live (green) and dead (red)
B. burgdorferi morphological forms was calculated by
counting these forms using a bacterial counting chamber and
fluorescent microscopy (see below). For the dark field and
fluorescent microscopy experiments, a Nikon Eclipse I–series
CF160 microscope was used (kindly donated by Dr Alan
MacDonald and Turn the Corner Foundation).

Qualitative analysis of biofilm-like
colonies
To qualitatively determine the effect of antibiotics on biofilmlike colonies of B. burgdorferi, 1 × 107 cells/mL from a
homogeneous culture of spirochetes were inoculated in a
collagen-coated four-well plate and incubated for 1 week.
After the 1-week incubation, biofilm-like colonies were seen
in the wells. These biofilm-like colonies were treated with
various concentrations of antibiotics diluted in PBS. Control
wells were treated with PBS alone, and cultures were run in
triplicate. Plates were incubated for 72 hours, and wells were
fixed with 500 µL of cold alcohol-formalin-acetic acid (AFA)
for 20 minutes. The wells were then stained with 200 µL of
2 × BacLight™ staining mixture for 15 minutes in the dark.
Coverslips were applied using fluorescent mounting media, and
pictures were immediately taken of control and treated wells.

Quantitative analysis of biofilm-like
colonies after treatment with antibiotics
To quantify B. burgdorferi biofilm-like colonies after treatment with various antibiotics, collagen-coated 24-well plates
were inoculated with 2 × 106 cells/mL from a homogeneous
culture of B. burgdorferi. The plates were incubated for
7 days to generate biofilm-like colonies, and then treated with
various concentrations of antibiotics diluted in PBS or with
PBS alone, as described above. The plates were incubated
for 72 hours, and wells were stained with 1 mL of crystal

Infection and Drug Resistance 2011:4

Antibiotic susceptibility of Borrelia burgdorferi

violet (0.1%) for 10 minutes. After 1 mL of 95% ethanol
was added to extract stain, the biofilm-like colonies were
washed twice with PBS and visualized at an optical density
of 570 nm using a BioTek spectrophotometer.

Statistical analysis
Statistical analysis was performed by two-sample paired
t-test using NCSS statistical software (NCSS LLC,
Kaysville, UT).

Results
To compare results from different culture techniques, MIC
and MBC values for antibiotic treatments were calculated and
compared with published data (Table 1). The standard published microdilution method involves culturing B. burgdorferi
in microwell plates, while the new methodology made use of
2-mL polystyrene test tubes. We observed a significant difference in MIC and MBC values between the two methods.
Both MIC and MBC values were in agreement with published
data when evaluated by the microdilution protocol. Using the
novel culture tube method, MIC values increased .63-fold
for doxycycline, .333-fold for tigecycline, .333-fold for
amoxicillin, .833-fold for metronidazole, and .694-fold
for tinidazole, compared with our microdilution values
(Table 1). Furthermore, MBC values increased .8-fold
for doxycycline, .80-fold for tigecycline, .40-fold for
amoxicillin, .50-fold for metronidazole, and .25-fold for
tinidazole, compared with our microdilution values (Table 1).
Since these MIC and MBC results suggested that our novel
method used more optimal culture conditions that allowed
the organisms to resist antibiotic treatment, we based further
experiments on this method.
To evaluate in-vitro antibiotic sensitivity of spirochete and round body morphological forms, two strains of
B. burgdorferi (B31 and S297) were incubated for 72 hours
with different antibiotics at concentrations above the calculated MIC and MBC. Antibiotic sensitivity was evaluated
using the direct cell counting and dark field morphological
evaluation methods (Figure 1). Treatment with these higher
concentrations showed that doxycycline reduced spirochetal
structures ∼90% but increased the number of cystic round
body forms about twofold (Figure 1A). Treatment with
metronidazole led to reduction of both spirochetal and cystic round body forms by ∼70% (Figure 1B). Treatment with
either tigecycline or tinidazole reduced both spirochetal and
cystic round body forms by ∼80%–90% (Figures 1C and 1D).
Amoxicillin reduced spirochetal structures ∼70% and cystic
round body forms by ∼68% (Figure 1E). No difference was
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Table 1 MIC and MBC determination by different methodsa
Antibiotics

Microdilution
Microdilution
Our data (MIC) µg/mL
Our data (MBC) µg/mL
method/literature Microdilution Direct cell BacLight™ method/literature Microdilution Direct cell BacLight™
data (MIC) µg/mL method
data (MBC) µg/mL method
counting staining
counting staining

Doxycycline
Tigecycline
Amoxicillin
Metronidazole
Tinidazole

0.06–2.00
0.006
0.03–2.00
0.06–32.00
–

0.4
0.015
0.3
0.3
0.09

.25
.5
.100
.250
.62.5

.25
.5
.100
.250
.62.5

0.25–6.40
0.05
,0.03–32.00
.4
.128

25
0.125
5
10
10

.200
.10
.200
.500
.250

.200
.10
.200
.500
.250

Notes: aComparison of MIC and MBC values for different antibiotics by standard microdilution method (published literature and our data) and novel direct cell counting and
fluorescent BacLight™ staining methods in reference to spirochete forms of Borrelia burgdorferi B31.
Abbreviations: MBC, minimum bactericidal concentration; MIC, minimum inhibitory concentration.

seen in antibiotic sensitivity testing between the two strains of
B. burgdorferi (B31 and S297). Using this method, we found
that the most effective doses of the antibiotics against the spirochete forms of B. burgdorferi were 250 µg/mL for doxycycline, 250 µg/mL for metronidazole, 20 µg/mL for tigecycline,
500 µg/mL for tinidazole, and 250 µg/mL for amoxicillin.
To examine in-vitro persistence of spirochete and round
body forms of B. burgdorferi, the B31 and S297 strains were
incubated for 72 hours and then evaluated by the direct cell
counting and dark field evaluation methods (Figure 2). As in the
previous set of experiments, doxycycline was found to be more
effective against spirochetes while metronidazole and tinidazole
were more effective against round body forms (Figure 2A). To
test the concept that by discontinuing antibiotics, spirochete
forms persist and cystic round body forms convert back to
spirochete forms, the treated cultures were sub-cultured in fresh
medium without antibiotics. After 3 weeks of subculturing,
doxycycline had reduced spirochetal forms by ∼45% and round
bodies by ∼85%, suggesting that round body forms converted
back to spirochete forms in more favorable growth conditions
(fresh growth medium and no antibiotic stress). Similarly,
metronidazole reduced spirochetal forms by ∼50% and round
bodies by ∼80%, while tinidazole reduced spirochetal forms
by ∼94% and round bodies by ∼96% (Figure 2B).
To confirm preliminary results, the B31 and S297
strains of B. burgdorferi were further evaluated in vitro for
antibiotic sensitivity of spirochete and round body morphological forms by a fluorescent microscopy technique
(BacLight™ staining). B. burgdorferi was incubated for
72 hours with antibiotics at concentrations higher than their
calculated MIC and MBC. In this set of experiments, we
calculated the post-treatment ratio of live/dead spirochetes
and round bodies using SYTO®9 green-fluorescent nucleic
acid stain (live cells) and propidium iodide red-fluorescent
nucleic acid stain (dead cells) (Figure 3A). Doxycycline
treatment reduced spirochetes by ∼94% but in the remaining

100

submit your manuscript | www.dovepress.com

Dovepress

6% of the population, ∼5% were still alive (stained green)
while ∼1% were dead (stained red). Tinidazole treatment
reduced spirochetes by ∼95%, but in the remaining 5% of
the population ∼3% were still alive while ∼2% were dead.
Tigecycline treatment was most effective as this reduced
spirochetes by ∼98%, and in the remaining 2% of the
population ∼1.5% were still alive and ∼0.5% were dead.
Metronidazole treatment reduced spirochetes by ∼54%,
but in the remaining 46% of the population ∼45% were
still alive and only ∼1% were dead. Amoxicillin treatment
reduced spirochetes by ∼69%, but in the remaining 31% of
the population ∼30% were alive and only ∼1% cells were
dead (Figure 3A).
Doxycycline treatment increased round bodies by ∼275%
(Figure 3B). Out of this population ∼270% were alive and
only ∼5% were dead. Tinidazole treatment reduced round
bodies by ∼94%, but in the remaining 6% of the population
only ∼2% were dead. Tigecycline treatment reduced round
bodies by ∼96%, but in the remaining 4% of population
only ∼1% were dead. Metronidazole treatment reduced
round bodies by ∼68%, but in the remaining 32% of the
population ∼15% were dead. Amoxicillin treatment reduced
round bodies by ∼32%, but in the remaining 68% of the
population ∼30% were dead (Figure 3B). The microscopic
appearance of the B31 and S297 strains of B. burgdorferi
following treatment with each antibiotic is shown in Figures
3C and 3D, respectively.
In the next experiments, a biof ilm-like form of
B. burgdorferi was evaluated quantitatively using a crystal
violet staining method and qualitatively using the fluorescent
microscopy technique (BacLight™ staining) (Figure 4).
Using the quantitative staining method, doxycycline reduced
biofilm-like colonies by ∼40%, tinidazole reduced biofilmlike colonies by ∼50%–55%, tigecycline reduced biofilm-like
colonies by ∼35%, and amoxicillin and metronidazole reduced
biofilm-like colonies by ∼30% (Figure 4A). For qualitative
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Effect of doxycycline at different concentrations on
B. burgdorferi-B31 strain after 72 hours

A
400

*

350

*

Percentage of control

Spirochetes
300
Round bodies
250
200
150
100
50

*

*

*

0
Control

B

25 µg/mL
Doxycycline

250 µg/mL
Doxycycline

500 µg/mL
Doxycycline

Effect of doxycycline at different concentrations on
B. burgdorferi-S297 strain after 72 hours
400
Spirochetes

*

350

*

Percentage of control

Round bodies
300
250
200
150
100
50

*

*

*

0
Control

25 µg/mL
Doxycycline

250 µg/mL
Doxycycline

500 µg/mL
Doxycycline

Figure 1A Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to different concentrations
(between calculated MIC and MBC) of five antibiotics after 72-hour treatment measured by dark-field microscopy.
Note: *P values ,0.05 indicates statistical significance compared with control.

analysis of bacterial cells in biofilm-like colonies, cultures
were treated as described above for 72 hours and stained
with BacLight™ fluorescent viability stain (Figure 4B).
In the absence of antimicrobial agents, B. burgdorferi form
biofilm-like colonies in which ∼98% of the colonies stain

Infection and Drug Resistance 2011:4

green (live cells) and ∼2% red (dead cells) (Figure 4Ba).
Doxycycline-treated colonies were similar in size to control
colonies and ∼70% stained green and ∼30% stained red
(Figure 4Bb). Tinidazole-treated colonies were very tiny and
loose in their morphology, and ∼10% stained green and ∼90%
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A

Effect of metronidazole at different concentrations on
B. burgdorferi-B31 strain after 72 hours

120

Percentage of control
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*

80

Spirochetes

*

Round bodies
60

*
*

40

*

*

20

0
Control

B

25 µg/mL
Metronidazole

250 µg/mL
Metronidazole

500 µg/mL
Metronidazole

Effect of metronidazole at different concentrations on
B. burgdorferi-S297 strain after 72 hours

120

Percentage of control

100

*

Spirochetes

80

*
60

Round bodies

*
*

40

*

*

20

0
Control

25 µg/mL
Metronidazole

250 µg/mL
Metronidazole

500 µg/mL
Metronidazole

Figure 1B Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to different concentrations
(between calculated MIC and MBC) of five antibiotics after 72-hour treatment measured by dark-field microscopy.
Note: *P values ,0.05 indicates statistical significance compared with control.

stained red (Figure 4Bc). Tigecycline-treated colonies were
similar in size to control colonies, and ∼70% stained green
and ∼30% stained red (Figure 4Bd). Metronidazole-treated
and amoxicillin-treated colonies were larger in size than
control colonies, and ∼80%–85% stained green while ∼20%
stained red (Figure 4Be and 4Bf).
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Discussion
The goal of our study was to demonstrate the in-vitro susceptibility of different morphological forms of B. burgdorferi
to various antibiotics using improved technical approaches
in order to understand why antibiotic treatment for patients
with Lyme disease could fail. To successfully eradicate
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A
120

Effect of tinidazole at different concentrations on
B. burgdorferi-B31 strain after 72 hours

Percentage of control
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80
Round bodies
60

40

20

*

*

*

*

*

*

0
Control

B
120

Tinidazole
62.5 µg/mL

Tinidazole
250 µg/mL

Tinidazole
500 µg/mL

Effect of tinidazole at different concentrations on
B. burgdorferi-S297 strain after 72 hours
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0
Control

Tinidazole
62.5 µg/mL

Tinidazole
250 µg/mL

Tinidazole
500 µg/mL

Figure 1C Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to different concentrations
(between calculated MIC and MBC) of five antibiotics after 72-hour treatment measured by dark-field microscopy.
Note: *P values ,0.05 indicates statistical significance compared with control.

B. burgdorferi, antimicrobial agents should eliminate all
morphological forms of the organism. Furthermore, for
better demonstration of antibiotic susceptibility of different
morphological forms of B. burgdorferi, there is a need for
reliable in-vitro testing methods.
The spirochete form of B. burgdorferi is the most active
form, with periplasmic flagella that make the organisms

Infection and Drug Resistance 2011:4

motile.15,16 Spirochetes can also enter into tissues and cause
intracellular infection.17,18 Adverse environmental conditions
such as change in temperature, pH, starvation, and most
importantly antibiotic exposure can cause a phenotypic
change in the spirochete.19,20 This change involving surface
proteins is hypothesized to be the way in which the spirochete
evades the host immune system.
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A

Effect of tigecycline at different concentrations on
B. burgdorferi-S297 strain after 72 hours
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5 µg/mL
Tigecycline
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Effect of tigecycline at different concentrations on
B. burgdorferi-S297 strain after 72 hours
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Tigecycline

10 µg/mL
Tigecycline

20 µg/mL
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Figure 1D Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to different concentrations
(between calculated MIC and MBC) of five antibiotics after 72-hour treatment measured by dark-field microscopy.
Note: *P values ,0.05 indicates statistical significance compared with control.

The change in phenotypic expression could also lead to
structural alterations in the spirochete form and induction
of the cyst form, a knob-shaped structure containing one or
multiple spirochetes.21–24 Cysts have a low metabolic rate
that enables them to survive in a hostile environment until

104

submit your manuscript | www.dovepress.com

Dovepress

conditions become favorable for them to multiply again.21–25
These cyst forms have been detected in spinal fluid, and have
been linked to neuroborreliosis.22 The spirochetes can also disintegrate into minute particles called granules.25 These granules are liberated through the periplasmic sheath surrounding
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A
120

Effect of amoxicillin at different concentrations on
B. burgdorferi-B31 strain after 72 hours
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Effect of amoxicillin at different concentrations on
B. burgdorferi-S297 strain after 72 hours
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Figure 1E Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to different concentrations
(between calculated MIC and MBC) of five antibiotics after 72-hour treatment measured by dark-field microscopy.
Note: *P values ,0.05 indicates statistical significance compared with control.

the spirochete body by budding and extrusion, and they may
also be transmissible.25 Both cysts and granules are together
referred to as round body forms in this study. Several studies
have shown that B. burgdorferi can convert from the spirochete
form to the round body form in vitro when presented with an

Infection and Drug Resistance 2011:4

unfavorable environment, and the organism can revert back to
the spirochete form when conditions are again favorable for
growth.21–24 The presence of atypical forms of B. burgdorferi
may be the reason why the spirochete can survive in infected
tissues for years or even for decades.21–24
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Effect of tinidazole, metronidazole and doxycycline at different
concentrations on B. burgdorferi-B31 strain after 72 hours
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Effect of tinidazole, metronidazole and doxycycline at different
concentrations on B. burgdorferi-S297 strain after 72 hours
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Figure 2A Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to the most effective
concentrations of three antibiotics measured by dark-field microscopy. Tinidazole, metronidazole, and doxycycline effect on B. burgdorferi after 72-hour treatment.
Note: *P values ,0.05 indicates statistical significance compared with control.

In addition to round body forms, we and others recently
noted that B. burgdorferi has the capability to form organized
structures called biofilm-like colonies.26,27 Biofilms are
adherent polysaccharide-based matrices that protect bacteria
from the hostile host environment and facilitate persistent
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infection.28–30 These organized structures are responsible
for a number of chronic infections, including periodontitis,
chronic otitis media, endocarditis, gastrointestinal infection,
and chronic lung infection. Formation of biofilm-like colonies
would allow B. burgdorferi to survive various environmental
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Effect of tinidazole, metronidazole and doxycycline at different
concentrations on B. burgdorferi-S297 strain after 3 weeks
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Figure 2B Susceptibility of the spirochete and round body forms of strain B31 (top panels) and strain S297 (bottom panels) of B. burgdorferi to the most effective
concentrations of three antibiotics measured by dark-field microscopy. Tinidazole, metronidazole, and doxycycline effect on B. burgdorferi after 3 weeks of subculturing
following 72-hour treatment.
Note: *P values ,0.05 indicates statistical significance compared with control.

stresses including exposure to antibacterial agents.28–30 Recent
studies suggest that bacteria live in an environment deep within
the biofilm-like colonies where diffusion of antibiotics might be
difficult, and in that state the bacteria could become 1000 times
more resistant to antibiotics.28–30 This resistance could also be
one of the reasons why conventional antibiotic therapy that
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is usually effective against free-floating bacteria becomes
ineffective once a pathogen forms biofilm-like colonies.28–30
In this study, novel methods of in-vitro antibiotic
susceptibility evaluation were used. These methods include
optimal culture and treatment conditions such as the culture
apparatus (tubes, to limit oxygen content), temperature, density
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Percentage live and dead spirochetes after treatment of B31 strain with different
antibiotics at their most effective concentration after 72 hours
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Percentage live and dead spirochetes after treatment of S297 strain with different
antibiotics at their most effective concentration after 72 hours
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Figure 3A Evaluation of live/dead spirochete and round body forms of B. burgdorferi following treatment with five antibiotics measured by fluorescent microscopy using
SYTO®9 green-fluorescent stain (live organisms) and propidium iodide red-fluorescent stain (dead organisms). Effect of doxycycline, tinidazole, tigecycline, metronidazole,
and amoxicillin on spirochete forms of strain B31 (top panel) and strain S297 (bottom panel).
Notes: *P values calculated were ,0.05 indicating statistical significance compared with control for live and dead spirochetes.

of inoculum, amount of culture medium, and CO2 level.34,35
These methods should counteract problems with culture variability of B. burgdorferi strains that have been described in the
past.36,37 Furthermore our novel procedures involve better bacterial viability determination methods such as fluorescent and
dark field microscopy. These microscopic evaluation methods
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are more reliable and sensitive than the standard published
bacterial viability determination protocols.38,39 Being metabolically inactive, round body forms of B. burgdorferi could
not be detected by standard protocols, but they can be directly
visualized under the microscope by our novel evaluation
methods. This explains why the standard protocols measure
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Figure 3B Evaluation of live/dead spirochete and round body forms of B. burgdorferi following treatment with five antibiotics measured by fluorescent microscopy using
SYTO®9 green-fluorescent stain (live organisms) and propidium iodide red-fluorescent stain (dead organisms). Effect of doxycycline, tinidazole, tigecycline, metronidazole and
amoxicillin on round body forms of strain B31 (top panel) and strain S297 (bottom panel).
Notes: *P values calculated were ,0.05 indicating statistical significance compared with control for live and dead round bodies.

effectiveness of antibiotics only in reference to metabolically
active spirochete forms while our novel antibiotic sensitivity
study measures effectiveness of antibiotics in reference to all
morphological forms of B. burgdorferi.
We found that doxycycline signif icantly reduced
the spirochete form of B. burgdorferi (∼90%) but also
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increased the round body forms twofold. Amoxicillin
reduced spirochetal forms by ∼85%–90% and round
body forms by ∼68%. In contrast, metronidazole, tinidazole, and tigecycline significantly decreased both the spirochete and the round body forms of B. burgdorferi, but
live organisms could still be detected following treatment
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Figure 3C Evaluation of live/dead spirochete and round body forms of B. burgdorferi
following treatment with five antibiotics measured by fluorescent microscopy using
SYTO®9 green-fluorescent stain (live organisms) and propidium iodide red-fluorescent
stain (dead organisms). Visualization of spirochete and round body forms of strain B31
following antibiotic treatment measured by dark field microscopy: (Ca) Control; (Cb)
Doxycycline; (Cc) Tinidazole; (Cd) Metronidazole; (Ce) Tigecycline; (Cf) Amoxicillin.
Note: All images taken at 40× magnification.

Figure 3D Evaluation of live/dead spirochete and round body forms of B. burgdorferi
following treatment with five antibiotics measured by fluorescent microscopy
using SYTO®9 green-fluorescent stain (live organisms) and propidium iodide
red-fluorescent stain (dead organisms). Visualization of spirochete and round
body forms of strain S297 following antibiotic treatment measured by dark field
microscopy: (Da) Control; (Db) Doxycycline; (Dc) Tinidazole; (Dd) Metronidazole;
(De) Tigecycline; (Df) Amoxicillin.
Note: All images taken at 40× magnification.

with these agents. Furthermore, the antibiotics studied
were equally effective or ineffective against two different
strains (B31 and S297) of B. burgdorferi. This observation
confirms the reliability of our experimental technique. It
remains to be seen whether combinations of antibiotics
would be more effective than individual antibiotics alone
in our in-vitro culture system.
Our results delineate antibiotic concentrations that are
effective in vitro. Whether equivalent concentrations can
be attained with clinical use of these agents in vivo remains
to be determined.39–45 An in-vitro study showed that tigecycline destroyed the spirochete and round body forms of
B. burgdorferi.39 However, an in-vivo study in mice showed
that tigecycline was ineffective during the late stage of Lyme
disease based on the persistence of viable and infectious but
nondividing or slowly dividing organisms in the animals.46 Our
study demonstrated that tigecycline was effective against the

spirochete and round body forms of B. burgdorferi but was not
effective against the biofilm-like mass. One possible explanation for the conflicting in-vitro and in-vivo results could be
the presence of these biofilm-like colonies in the late stage
of the disease, which renders B. burgdorferi more resistant
against the antibiotic. Another possibility is that intracellular
invasion of the spirochete in vivo could protect it from the
action of antibiotics.17,18 Further evaluation of B. burgdorferi
localization in tissues and biofilm-like masses is warranted.
To summarize, this study outlines novel in-vitro methods
to determine optimal growth conditions for B. burgdorferi. The
study also describes novel microscopic viability determination
methods to assess three morphological forms of B. burgdorferi
(spirochetes, round bodies, and biofilm-like colonies), and the
methods were used to evaluate antibiotic susceptibility of the
different morphological forms of this complex organism. Our
in-vitro methodology will facilitate the design of experiments
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Quantitative analysis of B31 biofilm like colonies after treatment with
antibiotics by crystal violet protocol
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Quantitative analysis of S297 biofilm like colonies after treatment with
antibiotics by crystal violet protocol
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Figure 4A Evaluation of biofilm-like colonies of B. burgdorferi. Quantitative analysis of biofilm-like colonies of strain B31 (top panel) and strain S297 (bottom panel) measured
by crystal violet staining technique.

that mimic tissue-based in-vivo conditions in order to optimize
the antibiotic treatment of Lyme disease.
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